Ticker
AADI

Price
7.21
Stock movement down
-0.49 (-6.36%)
Company name
Aadi Bioscience Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Marktkapitalisatie
175.89M
Ent waarde
66.07M
Prijs/Verkoop
16.01
Prijs/Boek
1.04
Div opbrengst
-
Div groei
-
Jaren van groei
-
FCF-uitkering
-4.62%
Trailing P/E
-
Toekomstige P/E
-
PEG
-
EPS-groei
-
1 jaar rendement
-59.79%
3 jaar rendement
-58.87%
5 jaar rendement
-63.58%
10 jaar rendement
-
Laatst bijgewerkt: 2023-03-22
Aadi Bioscience, Inc. (NASDAQ:NASDAQ:AADI) Q4 2022 Earnings Conference Call March 28, 2023 8:30 AM ETCompany ParticipantsMarcy Graham - Senior Vice President of Investor Relations and...
28 maart 2023

iO Charts is a Seeking Alpha partner

The following slide deck was published by Aadi Bioscience, Inc.
28 maart 2023

iO Charts is a Seeking Alpha partner

DIVIDENDEN

AADI keert geen dividend uit
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
28 maart 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
27 maart 2023

iO Charts is a Seeking Alpha partner

WAARDERING

Waarderingsverhoudingen

Loading...
Gegevens over waarderingsratio's
Trailing P/E-
Prijs tot OCF-
Prijs tot FCF-
Prijs tot EBITDA-
EV tot EBITDA-

Waardering (verkoop/boekwaarde)

Loading...
Waarderingsgegevens (verkoop/boekwaarde)
Prijs tot verkoop16.01
Prijs te boeken1.04
EV naar verkoop6.01
Aadi Bioscience is a commercial stage company with a potential label expansion ahead. Click here to learn why I rate AADI stock a Buy.
7 maart 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
3 maart 2023

iO Charts is a Seeking Alpha partner

FINANCIËN

Per aandeel

Loading...
Gegevens per aandeel
Huidig aantal aandelen24.40M
WPA (TTM)-2.94
FCF per aandeel (TTM)-3.84

Resultatenrekening

Loading...
Gegevens van de resultatenrekening
Inkomsten (TTM)10.99M
Brutowinst (TTM)10.00M
Bedrijfsresultaat (TTM)-63.16M
Netto inkomsten (TTM)-62.59M
WPA (TTM)-2.94
Winst per aandeel (1 jaar vooruit)-2.53

Marges

Loading...
Margegegevens
Brutomarge (TTM)90.96%
Operationele marge (TTM)-574.71%
Winstmarge (TTM)-569.57%

Balans

Loading...
Maak een gratis account aan of log in om toegang te krijgen tot deze grafiek.
Balansgegevens
Cash134.81M
Netto vorderingen2.26M
Totaal vlottende activa189.86M
Goodwill0.00
Immateriële activa0.00
Materiële vaste activa0.00
Totaal activa194.10M
Crediteuren3.92M
Schuld op korte/lange termijn1.72M
Totaal vlottende passiva17.89M
Totaal passiva25.00M
Eigen vermogen169.11M
Netto materiële activa169.11M

Kasstroom

Loading...
Maak een gratis account aan of log in om toegang te krijgen tot deze grafiek.
Kasstroomgegevens
Bedrijfskasstroom (TTM)-80.89M
Investeringsuitgaven (TTM)676.00K
Vrije kasstroom (TTM)-81.57M
Betaalde dividenden (TTM)3.77M

Financieel rendement

Loading...
Maak een gratis account aan of log in om toegang te krijgen tot deze grafiek.
Gegevens over financieel rendement
Rendement op eigen vermogen-37.01%
Rendement op activa-32.25%
Rendement op geïnvesteerd kapitaal-36.93%
Contant rendement op geïnvesteerd kapitaal-48.13%
Aadi Bioscience, Inc. (NASDAQ:NASDAQ:AADI) Q3 2022 Earnings Conference Call November 9, 2022 8:30 AM ETCompany ParticipantsMarcy Graham - Senior Vice President of Investor Relations &...
9 november 2022

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
9 november 2022

iO Charts is a Seeking Alpha partner

VOORRAADINFORMATIE

Voorraadgrafiek

Loading...
Koersgegevens
Open7.72
Dagelijks hoog7.72
Dagelijks laag7.20
Dagelijks volume120K
Hoogtepunt aller tijden1485.00
1y analistenraming41.67
Beta-
WPA (TTM)-2.94
Dividend per aandeel-
Ex-div datum-
Volgende inkomsten datum28 Mar 2023

Negatief potentieel

Loading...
Nadeel potentiële gegevens
AADIS&P500
Huidige prijsdaling vanaf het hoogste punt ooit-99.51%-17.92%
Hoogste prijsdaling-99.51%-56.47%
Datum van hoogste daling22 Mar 20239 Mar 2009
Gemiddelde daling vanaf de top-76.27%-11.51%
Gemiddelde tijd tot nieuwe high72 days13 days
Max tijd tot nieuwe hoogte1337 days1805 days
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
8 november 2022

iO Charts is a Seeking Alpha partner

The following slide deck was published by Aadi Bioscience, Inc.
3 november 2022

iO Charts is a Seeking Alpha partner

BEDRIJFSGEGEVENS
AADI (Aadi Bioscience Inc) company logo
Marketcap
175.89M
Marketcap categorie
Small-cap
Beschrijving
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.
Werknemers
76
Investeerdersrelaties
-
SEC-dossiers
CEO
Land
USA
Stad
Type voorraad
-
CCC-status
-
Dividendfrequentie
-
EVENEMENTEN EN PRESENTATIES
EvenementenPresentaties
Loading...
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
12 oktober 2022

iO Charts is a Seeking Alpha partner

The following slide deck was published by Aadi Bioscience, Inc.
30 september 2022

iO Charts is a Seeking Alpha partner

HET BEDRIJF BEGRIJPEN
Loading...
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
22 september 2022

iO Charts is a Seeking Alpha partner

Aadi Bioscience shares lost half their value since reverse merger with Aerpio Pharmaceuticals. Click here to read why AADI stock is a Buy in my view.
21 september 2022

iO Charts is a Seeking Alpha partner

BEDRIJFSNIEUWS
Alle nieuwsPersberichten
Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, ...
28 maart 2023
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTO...
27 maart 2023
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTO...
26 maart 2023
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTO...
15 maart 2023
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announce...
3 maart 2023
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTO...
22 februari 2023
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTO...
17 november 2022
Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, ...
9 november 2022
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announce...
8 november 2022
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTO...
3 november 2022
Volgende pagina
Aadi Bioscience, Inc. (NASDAQ:NASDAQ:AADI) Q2 2022 Earnings Conference Call August 10, 2022 8:30 AM ETCompany ParticipantsMarcy Graham - SVP of IR and Corporate CommunicationsNeil Desai -...
10 augustus 2022

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
10 augustus 2022

iO Charts is a Seeking Alpha partner